Skip to main content
Clinical Trials/EUCTR2017-000709-18-NL
EUCTR2017-000709-18-NLActive, not recruitingPhase 1

The effect of erector spinae block on postoperative pain and opioid use in patients undergoing breast cancer surgery with sentinel node dissection

Bernhoven0 sites10 target enrollmentStarted: April 12, 2017Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • ->18 years old
  • -ASA I-III
  • -Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • -Allergy or contra-indication for paracetamol or etoricoxib
  • -Chronic opioid use
  • -Known hypersensitivity or contraindication for local anesthetics
  • -Bleeding or infection at the puncture site
  • -Contraindications for regional anesthesia
  • -Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study

Investigators

Sponsor
Bernhoven

Similar Trials

The analgesic efficacy of Erector Spinae... | Clinical Trial